arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

download Export Data

Alzamend Neuro, Inc.

ALZN

$1.38 0.00 (0.00%) at close

26 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Alzamend Neuro, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -103.1% ↘

FCF / Share None

Trailing P/E —

Price / Book 2.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-2.87M

↓ -151.9% —

FCF / Share Free cash flow per share

$-0.46

↓ -31.7% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -314.8% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -1324.50x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.92x is caution on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q4 FY2019 Apr 30, 2019 10-K ↗
EPS Growth YoY (%)	58.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-205.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	-2.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	98.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	9.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-3025.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-462.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-533.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1366.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-33.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-42120.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-151.9% Weak ↓ Weak Declining Year-over-year change in net income	-111.6% Weak ↓ Weak Declining Year-over-year change in net income	29.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-177.4% Weak ↓ Weak Declining Year-over-year change in net income	-33.8% Weak ↓ Weak Declining Year-over-year change in net income	61.0% Excellent ↓ Excellent Declining Year-over-year change in net income	51.3% Excellent ↓ Excellent Declining Year-over-year change in net income	72.4% Excellent ↑ Excellent Improving Year-over-year change in net income	74.2% Excellent ↑ Excellent Improving Year-over-year change in net income	50.9% Excellent ↑ Excellent Improving Year-over-year change in net income	6.6% Fair ↑ Fair Improving Year-over-year change in net income	-16.2% Weak ↑ Weak Improving Year-over-year change in net income	14.6% Fair ↑ Fair Improving Year-over-year change in net income	-110.9% Weak ↓ Weak Declining Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	-30.9% Weak ↑ Weak Improving Year-over-year change in net income	-207.9% Weak ↓ Weak Declining Year-over-year change in net income	-129.9% Weak ↓ Weak Declining Year-over-year change in net income	-165.9% Weak Weak Year-over-year change in net income	-76.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	17.3% Good Good Year-over-year change in free cash flow	—	—	—	-3951.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q4 FY2019 Apr 30, 2019 10-K ↗
FCF / Net Income (x)	0.97x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.68x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q4 FY2019 Apr 30, 2019 10-K ↗
Return on Invested Capital (%)	-103.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-79.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	62.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	25.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	49.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	85.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	2467.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-85.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-73.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-22.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	68.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	153.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-4026.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-138.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-134.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-339.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-295.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-134.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-55.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-26.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-41.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-130.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-970%)	-100.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-771%)	-22.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-50.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-437%)	-28.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-30.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-301%)	-37.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-351%)	80.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+436%)	32.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+119%)	62.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+316%)	108.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+622%)	—	-108.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-824%)	-92.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-717%)	-35.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-336%)	-27.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-29.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-293%)	-21.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-27.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-62.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-516%)	86.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+476%)	203.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1254%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q4 FY2019 Apr 30, 2019 10-K ↗
Interest Coverage (x)	-19139.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1643.72x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-376.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1087.48x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-2237.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-513.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-388.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-80.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-580.25x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1069.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-673.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1921.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6368.03x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2630.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-865.78x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1981.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6433.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-156.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-224.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-169.23x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-35.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-25.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8730.51x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-710.69K	$-2.71M	$-4.45M	$-5.62M	$-3.95M	$-3.36M	$-4.09M	$-1.19M	$-376.05K	$-282.87K	$-200.08K	$-1.70M	$-5.14M	$-7.38M	$-9.18M	$-11.53M	$-14.06M	$-11.79M	$-13.57M	$-15.62M	$-1.93M	$-40.74K	$-5.86K	$-63.11K	$-90.28K	$-42.61K

📊 What does each share earn? 5 metrics

Metric	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q4 FY2019 Apr 30, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.74	$-0.58	$-0.30	$-1.28	$-1.78	$-0.19	$-0.40	$-1.25	$-118.81	$-0.38	$-0.44	$-0.04	$-21.11	$-0.06	$-0.03	$-0.03	$-0.05	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-0.46	$-0.35	$-1.12	—	—	—	$-1.36	—	—	—	$-0.03	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.52	$0.57	$1.15	$1.70	$5.10	$0.60	$0.72	$-1.41	—	$-0.64	$-0.41	$-0.00	$4.71	$0.06	$0.09	$0.12	$0.14	—	—	$0.18	$0.03	—	—	—	$0.01	—
Tangible Book Value per Share (USD)	$0.52	$0.57	$1.15	$1.70	$5.10	$0.60	$0.72	$-1.41	—	$-0.64	$-0.41	$-0.00	$4.71	$0.06	$0.09	$0.12	$0.14	—	—	$0.18	$0.03	—	—	—	$0.01	—
Basic Weighted Avg Shares (shares)	—	3.80M	3.38M	2.11M	—	5.52M	3.53M	777,821	—	7.05M	6.56M	98.44M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q4 FY2019 Apr 30, 2019 10-K ↗
Working Capital (USD)	—	—	—	—	—	—	—	—	—	$-3.23M	—	—	—	$5.77M	$8.70M	$11.09M	$13.25M	$11.96M	$13.03M	$15.34M	$2.01M	—	—	—	$821.71K	—
Total Equity (USD)	$2.20M	$2.18M	$4.37M	$5.34M	$3.97M	$3.45M	$3.75M	$-1.21M	$-2.59M	$-4.26M	$-2.68M	$-112.88K	$3.05M	$5.86M	$8.79M	$11.18M	$13.35M	$11.96M	$13.03M	$15.34M	$2.01M	$-1.30M	$-666.77K	$25.87K	$821.71K	$316.92K

📋 What is driving earnings? 3 metrics

Metric	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q4 FY2019 Apr 30, 2019 10-K ↗
Depreciation Expense (USD)	$27.68K	$27.68K	$27.68K	$27.68K	$12.69K	—	—	$12.69K	$12.69K	—	—	$12.69K	$5.32K	—	—	$7.10K	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-2.87M	$-2.20M	$-1.00M	$-2.70M	$-1.14M	$-1.04M	$-1.42M	$-974.41K	$-851.53K	$-2.66M	$-2.91M	$-3.53M	$-3.31M	$-5.43M	$-3.11M	$-3.04M	$-3.87M	$-2.57M	$-3.60M	$-2.32M	$-1.26M	$-1.12M	$-1.35M	$-1.32M	—	—
Operating Cash Flow (USD)	$-2.80M	$-1.74M	$-1.17M	$-2.36M	$-688.71K	—	—	$-1.06M	$-1.43M	—	—	$-3.30M	$-2.24M	—	—	$-2.54M	$-1.56M	—	—	$-1.22M	$-1.26M	$-806.13K	$-442.93K	$-205.10K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 26 quarters

Alzamend Neuro, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare ALZN with peers